Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Epanutin

- PMLiVE

Pfizer acquires Baxter Men C and encephalitis vaccines for $635m

Snaps up marketed vaccines and part of Baxter's Austrian manufacturing plant

- PMLiVE

European licence for BMS/Pfizer’s Eliquis in DVT and PE

Anticoagulant catches up with Bayer's Xarelto and Boehringer's Pradaxa

- PMLiVE

Community pharmacies central to diabetes fight in UK

Risk assessments can help identify people at risk of developing condition

National Institute for Health and Care Excellence NICE logo

NICE confirms wider statin use

Reduces threshold for risk of heart disease

- PMLiVE

Pfizer inks $360m deal to buy InnoPharma

Boosts position in the buoyant sterile injectables market

UK flag

Cipla invests £100m in UK

Indian pharma company to fund both commercial and R&D activities

- PMLiVE

NICE backs Lundbeck’s alcohol dependence drug Selincro

Alcoholics in England to have access to once-daily drug

- PMLiVE

SMC decides Celgene’s Imnovid is not cost-effective

Scottish cancer patients denied access to the cancer drug

- PMLiVE

UK NHS needs to rethink long-term care

MPs call for system change as chronic conditions account for 70 per cent of yearly healthcare spend

- PMLiVE

New NHS CEO announces senior changes

Simon Stevens strengthens leadership within NHS England

UK flag

UK healthcare professionals urged to say ‘no’ to antibiotics

Royal Colleges issues joint statement to members warning of antimicrobial resistance

- PMLiVE

Novartis and NHS launch mobile eye unit in UK

First of its kind unit to offer 250 clinic slots per week across Surrey, Hampshire and Berkshire

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links